What is the Fate of Medtronic plc (NYSE:MDT) After Earnings?


Medtronic plc (NYSE:MDT) moved up 0.37% and closed its last trading session at $77.99. This Medical Sector stock currently has the Market Capitalization of 107.63 Billion. The Average Volume for the stock is measured as 6.67 Million. The Stock has a 52-Week High of $89.27 and 52-Week Low of $69.35 following the dates, it touched its 52-Week High on Jul 15, 2016 and 52-Week Low on Jan 3, 2017. Currently, the Return on Assets value for the trailing twelve months is 4.2% with the Return on Equity and Return on Investment of 8.3% and 5.3% respectively. This firm currently has YTD (year to date) performance of 9.49 Percent which is awesome. The Short Ratio for the stock is 1.46.

Medtronic plc (NYSE:MDT) Price to Earnings (P/E) ratio is 25.91. EPS or Earning per Share stands at $3.01. The TTM operating margin is 18.7 percent.

Medtronic plc (NYSE:MDT) reports its Earnings on Tue 21 Feb (In 5 Days). The estimated EPS for the current quarter is said to be $1.11. Following Earnings result, share price were DOWN 19 times out of last 28 Qtrs. The stock has reduced about -3% since it reported its last earnings. The Closing price of Medtronic plc (NYSE:MDT) at Last Earnings was $80.1 as compared to the previous closing price of $77.7. The Predicted Move on the 7th day after Medtronic plc (NYSE:MDT) will release its earnings at about 3%.

By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, Medtronic plc (NYSE:MDT) beats earnings by 66%, The Stock Missed Earnings  0 times and has met earnings  4  times.

Earnings History:

We will discuss the past Quarters Earnings below:

Medtronic plc (NYSE:MDT) reported its previous quarter on 11/22/2016 where it reported the Actual Earnings of $1.12. The Closing price before the company posted its earnings was $80.1. The Stock declined on the very next day of earnings and maintained its stock price at $73.16 by showing a % change of -8.66 percent from its previous closing price. The Next Day Volume after Earnings was reported as 31.14 Million. On the 7th day After Earnings Report, the stock hit its share price as $73.55 by showing -8.18% decrease from the Stock price Before Earnings were reported.

On 08/25/2016, the stock reported the EPS of $1.03 where Analysts were projecting the EPS to be $1.01 showing a difference of $0.02. Thus Surprise Factor was there with 2 percent. Before Earnings Announcement on 08/25/2016, the firm had its stock price of $85.71. And immediately on the next day after earnings announcement, the stock declined -1.46% and closed its trading session at $84.46. On 7th Day after earnings release, Medtronic plc (NYSE:MDT) surged to 0.43% from $85.71 to $86.08.

On 05/31/2016, Analysts were suspecting EPS of $1.26/share where Medtronic plc (NYSE:MDT) reported its Actual EPS of $1.27. Thus showing a Surprise of 0.8 percent. The Closing Price of the stock before earnings was $80.41 while on the Next day the stock closed its trading session at $79.21 with a percentage change of -1.49% from the price of 80.41 before Earnings. The Stock Closing Price on the 7th day of earnings was $82.4.

Company Profile:

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.